Reflections on the Fate of Cerebral Embolic Protection Devices With TAVR: The REFLECT II Trial

Nicolas van Mieghem; Joost Daemen

doi:10.1016/j.jcin.2020.12.021

Reflections on the Fate of Cerebral Embolic Protection Devices With TAVR: The REFLECT II Trial

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

63 Downloads (Pure)

Original language	English
Pages (from-to)	528-530
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	14
Issue number	5
DOIs	https://doi.org/10.1016/j.jcin.2020.12.021
Publication status	Published - 8 Mar 2021

Bibliographical note

Funding Information:
Dr. Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV, and Abiomed. Dr. Daemen has received institutional grant/research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Pie Medical, and ReCor medical.

Research programs

EMC COEUR-09

Access to Document

10.1016/j.jcin.2020.12.021

Repub_135180.pdfFinal published version, 109 KB

Cite this

@article{f9af666d2ab544db84b46ba00642aa28,

title = "Reflections on the Fate of Cerebral Embolic Protection Devices With TAVR: The REFLECT II Trial",

author = "\{van Mieghem\}, Nicolas and Joost Daemen",

note = "Funding Information: Dr. Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV, and Abiomed. Dr. Daemen has received institutional grant/research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Pie Medical, and ReCor medical.",

year = "2021",

month = mar,

day = "8",

doi = "10.1016/j.jcin.2020.12.021",

language = "English",

volume = "14",

pages = "528--530",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Reflections on the Fate of Cerebral Embolic Protection Devices With TAVR: The REFLECT II Trial

AU - van Mieghem, Nicolas

AU - Daemen, Joost

N1 - Funding Information: Dr. Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV, and Abiomed. Dr. Daemen has received institutional grant/research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Pie Medical, and ReCor medical.

PY - 2021/3/8

Y1 - 2021/3/8

UR - https://www.scopus.com/pages/publications/85101368577

U2 - 10.1016/j.jcin.2020.12.021

DO - 10.1016/j.jcin.2020.12.021

M3 - Article

C2 - 33663780

SN - 1936-8798

VL - 14

SP - 528

EP - 530

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 5

ER -

Reflections on the Fate of Cerebral Embolic Protection Devices With TAVR: The REFLECT II Trial

Bibliographical note

Research programs

Access to Document

Other files and links

Cite this